自验配与听力师验配助听器的长期效果比较
本研究为一项随机临床试验的随访比较效果研究,比较自验配非处方助听器与听力师验配助听器在8个月时的自报结局。64名试验参与者中44人纳入扩展研究,两组在APHAB全局评分和IOI-HA总分上无显著差异,自验配组IOI-HA总分随时间变化表现更好。
要点
- 8个月随访时,自验配组与听力师验配组在APHAB全局评分上无显著差异。
- 两组IOI-HA总分无显著差异,但自验配组随时间变化表现更好。
- 自验配非处方助听器可为轻中度听力损失者提供与听力师验配相当的长期获益。
核心结论
- 自验配非处方助听器可为轻中度听力损失者提供与听力师验配助听器相当的长期获益。
研究设计与样本
- 基于先前随机临床试验的随访比较效果研究,重新评估未失访的部分原参与者,缺失数据采用多重插补处理。
- 原非劣效性试验在南非比勒陀利亚大学开展,时间为2022年4月至2022年8月;本次分析时间为2023年7月7日至2023年11月20日。
- 原试验64名参与者中44人纳入扩展研究,听力师验配组21人(47.7%),自验配组23人(52.3%)。
- 参与者平均年龄63.0岁(标准差13.2),男性21人(47.7%)。
主要发现
- 长期随访时,自验配组与听力师验配组APHAB全局评分平均差异为0.02(95%CI -7.1至7.1;Cohen d 0.01,95%CI -0.5至0.5),无显著差异。
- IOI-HA总分平均差异为1.5(95%CI -1.4至4.4;Cohen d 0.3,95%CI -0.2至0.8),无显著差异。
- 从6周到8个月,APHAB全局评分未发现临床有意义的组别-时间交互作用(Cohen d 0.1,95%CI -0.2至0.3)。
- 从6周到8个月,IOI-HA总分发现显著交互作用(Cohen d -0.6,95%CI -0.8至-0.3),自验配组总体表现更好。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: With rising interest in over-the-counter (OTC) hearing aids as an alternative to traditional audiologist-fit devices, understanding their long-term efficacy is crucial. However, given the novelty of the US Food and Drug Administration category of OTC hearing aids, minimal evidence currently supports their long-term efficacy. OBJECTIVE: To compare the long-term self-reported outcomes at 8 months of self-fit OTC hearing aids to the same hearing aids fit by audiologists. DESIGN, SETTING, AND PARTICIPANTS: Building on a previous randomized clinical trial, this follow-up comparative effectiveness research study reassessed a number of the original participants that were not lost to follow-up. Participants were initially divided into those with self-fit OTC hearing aids and those with audiologist-fit devices. Approximately 8 months after fitting, participants completed self-reported questionnaires. Missing data were addressed through multiple imputation. The original noninferiority trial was conducted at the University of Pretoria in South Africa from April 2022 to August 2022. The current analysis took place between July 7, 2023, to November 20, 2023. INTERVENTIONS: In the original trial, participants in the self-fit device group received a pair of OTC hearing aids and independently fit them with remote support as needed. The audiologist-fit device group received the same hearing aids fit by a certified audiologist using best practices. MAIN OUTCOMES AND MEASURES: The main outcomes were self-reported hearing aid benefit, measured using the Abbreviated Profile of Hearing Aid Benefit (APHAB) and the International Outcome Inventory for Hearing Aids (IOI-HA). RESULTS: Of 64 participants in the trial, 44 participants were included in the extension study (21 [47.7%] in the audiologist-fit group; 23 [52.3%] in the self-fit group). The mean (SD) age of these participants was 63.0 (13.2) years, and 21 (47.7%) were male. At the long-term follow-up, self-fit and audiologist-fit groups showed no significant differences in the APHAB global score (mean difference, 0.02 [95% CI, -7.1 to 7.1]; Cohen d, 0.01 [95% CI, -0.5 to 0.5]) or the IOI-HA total score (mean difference, 1.5 [95% CI, -1.4 to 4.4]; Cohen d, 0.3 [95% CI, -0.2 to 0.8]). From 6 weeks to 8 months, no clinically meaningful group-time interaction was found between groups for the APHAB global score (Cohen d, 0.1 [95% CI, -0.2 to 0.3]), but a significant interaction for the IOI-HA total score was found (Cohen d, -0.6 [95% CI, -0.8 to -0.3]), with the self-fit group generally performing better. CONCLUSION: This comparative effectiveness research study demonstrated that self-fit OTC hearing aids can offer comparable long-term benefits to audiologist-fit hearing aids for individuals with mild to moderate hearing loss.
引用
- De Sousa KC, Manchaiah V, Moore DR, et al. Long-Term Outcomes of Self-Fit vs Audiologist-Fit Hearing Aids. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38990557. doi:10.1001/jamaoto.2024.1825
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。